Konnai, Katsuyuki
Fujiwara, Hiroyuki
Kitagawa, Masakazu
Wakabayashi, Reina
Yumori, Asuna
Notomi, Tsuguto
Onose, Ryo
Kato, Hisamori
Narimatsu, Hiroto
Article History
Received: 24 September 2022
Accepted: 22 February 2023
First Online: 27 February 2023
Declarations
:
: This study was submitted and approved by the Institutional Review Board of Kanagawa Cancer Center (Yokohama, Japan; 2021-EKI-110).All study participants provided written informed consent.This study was carried out following the Declaration of Helsinki.
: Not applicable.
: HN received research funding from Chugai Pharmaceutical Co., Ltd. All other authors have no conflict of interest relevant to this study.